'Health Ministry’s visit at the Paul-Ehrlich-Institut' – Thomas Müller, new head of the Medicinal Products Division of the German Federal Ministry of Health (BMG) visited the Paul-Ehrlich-Institut (PEI) on 2 May 2018
"We are very pleased to welcome Thomas Müller at the Paul-Ehrlich-Institut today and to introduce him to its wide range of duties in the field of biomedicine", said Klaus Cichutek, president of the Federal Institute for Vaccines and Biomedicines, which reports to the Federal Ministry of Health.
more: 'Health Ministry’s visit at the Paul-Ehrlich-Institut' – Thomas Müller, new head of the Medicinal Products Division of the German Federal Ministry of Health (BMG) visited the Paul-Ehrlich-Institut (PEI) on 2 May 2018 …
Fewer animal experiments in medicines testing: another success for the German federal institutes
On the occasion of the World Day for Laboratory Animals on 24 April, animal welfare organisations again demand a paradigm change and a withdrawal from animal experiments. In the case of regulatory animal experiments based on the legal requirements for the development and testing of medicines, the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines (PEI) has successfully committed itself for achieving these goals for decades.
TAV, scientific advice and Brexit in the focus of the meeting between PEI and the BPI
No matter whether the subject concerns the Therapieallergeneverordnung (TAV, Therapy Allergens Regulation), offers for regulatory scientific advice, or Brexit: These topics have in common that they require all actors to proceed in a harmonised manner.
"The active dialogue with associations of the pharmaceutical industry optimises the interfaces for development, marketing authorisation, and testing, and in doing so – ensures safe and effective biomedicines in Germany and Europe", explained Professor Klaus Cichutek, president of the PEI.